Return to Medscape coverage of: American Society of Clinical Oncology 35th Annual Meeting

Print this Activity for Offline ReferenceInstructions on Taking Medscape CME
American Society of Clinical Oncology 35th Annual Meeting
Day 2 - Sunday, May 16 CME
May 15, 1999 - November 15, 1999, Atlanta, Georgia

This activity is not sanctioned by, nor a part of, the American Society of Clinical Oncology 35th Annual Meeting. Click here for more information on this Medscape program.

Release Date: May 15, 1999; Valid for credit through November 15, 1999

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.


Contents of This CME Activity
    Lung Cancer: Breathing New Life Into Locally Advanced NSCLC and Stage IV Disease
    Corey J. Langer MD
    Locally Advanced NSCLC: Concurrent vs Sequential Therapy
    Corey J. Langer MD
    Optimizing Local Treatment of Early-Stage Prostate Cancer: Determining Which Patients Benefit From the Addition of Neoadjuvant Androgen Deprivation
    Diane M. Savarese MD
    Localized Prostate Cancer: What Are the Prognostic Criteria and the Best Approaches to Therapy?
    Nicholas J. Vogelzang MD
    New Tactics for Taxanes
    Edith A. Perez MD
    New Insights into Local-Regional Breast Cancer Therapy
    Joseph A. Sparano MD
    Weekly Taxanes and Liposomal Anthracyclines for Advanced Breast Cancer: Widening Studies in Clinical Practice; And MMP Inhibitors
    Harold J. Burstein MD PhD
    Biology is Destiny in Breast Cancer: But Whose Destiny?
    George W. Sledge, Jr MD
    Chemoprevention, Etiology, and a New Therapy for Squamous Cell Cancer of the Head and Neck
    Marshall Posner MD
    Ovarian Cancer: Defining "Standard Front-Line Chemotherapy"
    Maurie Markman MD
    Lymphoma '99: The Lows and the Highs
    Alexandra M. Levine MD
    Fludarabine-containing Regimens in Low-grade Lymphoma
    Alexandra M. Levine MD
    Leukemia and Myleoma: New Approaches, Novel Agents
    Moshe Talpaz MD
    Colorectal Cancer: Time for a New Standard?
    Leonard B. Saltz MD
    Colorectal Cancer: Therapeutic, Clinical, And Laboratory Correlates
    John S. MacDonald MD
    Immune and Other Investigational Therapies for Melanoma
    Jeffrey S. Weber MD, PhD
    Quality of Life and Hematopoietic Growth Factors
    Jeffrey Crawford MD
    Possible Metabolic Interaction Between Taxanes and Camptothecin Analogues
    William C. Zamboni PhD

 
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape, Inc., and do not represent a publication of the American Society of Clinical Oncology. These materials and the related activity are not sanctioned by the American Society of Clinical Oncology or the sponsors of the conference, and do not constitute an official part of that conference.
The material presented here does not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing medical education activity.
Copyright © 1999 Medscape Portals, Inc.

 
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.